4//SEC Filing
Jackson Richard L. 4
Accession 0001179110-12-000035
CIK 0001412067other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 3:17 PM ET
Size
9.3 KB
Accession
0001179110-12-000035
Insider Transaction Report
Form 4
Oncothyreon Inc.ONTY
Jackson Richard L.
Director
Transactions
- Exercise/Conversion
Common Stock
2011-12-31+2,388→ 29,893 total - Tax Payment
Common Stock
2011-12-31$7.58/sh−597$4,525→ 29,296 total - Exercise/Conversion
Restricted Share Units
2011-12-31−2,388→ 0 totalFrom: 2011-12-31Exp: 2011-12-31→ Common Stock (2,388 underlying)
Footnotes (4)
- [F1]Each restricted share unit was the economic equivalent of one share of common stock. On December 31, 2011, 2,388 of Dr. Jackson's restricted share units were settled for an equal number of shares of common stock.
- [F2]Reflects 12,624 restricted share units previously owned and 17,269 shares directly beneficially owned by Dr. Jackson.
- [F3]The shares were disposed of to the Issuer in a transaction approved by the board of directors in accordance with Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. The 597 shares represent 25% of the shares underlying the RSU grant to Dr. Jackson that vested on December 31, 2011 and the transaction is designed to facilitate Dr. Jackson's satisfaction of U.S. federal income tax obligations in connection with the vesting of such RSU grant. The Issuer's common stock was not traded on the vesting date. Accordingly, the price per share is equal to the closing price of the Issuer's common stock on December 30, 2011, the most recent date prior to the vesting date on which the Issuer's common stock was traded.
- [F4]Reflects 12,624 restricted share units previously owned and 16,672 shares directly beneficially owned by Dr. Jackson.
Documents
Issuer
Oncothyreon Inc.
CIK 0001412067
Entity typeother
Related Parties
1- filerCIK 0001418872
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 3:17 PM ET
- Size
- 9.3 KB